Patent Opposition Database

Hide annotations

Related patent application (please put in national patent application/publication number or PCT application/publication number): 8222/DELNP/2015
Who filed: Sujata Sharma
Country: India
Opposition type: Pre-Grant
Opposition status: Under Examination
Date: 01-07-2019
Patent type: Dosages

Click within the document, or manually enter the page number below

Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002757)

Countries: India Date: 2019
Ganesh Acharya and Delhi Network of Positive People (DNP+) opposition, Isoniazid-Rifapentine (3HP), (201637002758)

Countries: India Date: 2019
Biological E Limited opposition, Pneumococcal Conjugate Vaccine, (2182/DELNP/2015)

Countries: India Date: 2019
Biological E Limited opposition, Pneumococcal Conjugate Vaccine, (2183/DELNP/2015)

Countries: India Date: 2019
Henminlun opposition, Cabotegravir, (303371)

Countries: India Date: 2019
Sankalp Rehabilitation Trust (Sankalp Trust), Mumbai opposition, Cabotegravir, (637/KOLNP/2013)

Countries: India Date: 2019
Dr. Reddy Laboratories Limited opposition, Sacubitril / Valsartan, (4412/DELNP/2007)

Countries: India Date: 2019
Nandita Venkatesan and Phumeza Tisile (TB survivors) opposition, Bedaquiline Fumarate, (1220/MUMNP/2009)

Countries: India Date: 2019
Initiative for Medicines, Access & Knowledge (I-Mak) and Delhi Network of Positive People (DNP+) opposition, Glecaprevir, (2891/DELNP/2013)

Countries: India Date: 2019
Vee Excel Drugs & Pharmaceuticals opposition, Empaglifloin/Linagliptin (GLYXAMBI), (6148/DELNP/2011)

Countries: India Date: 2019

Sujata Sharma Opposition, Tofacitinib, (8222/Delnp/2015)